Charak G, et al. - Experts aspired to determine whether angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) use increased the risk of readmission, or readmission specifically for dehydration after new ileostomy creation. A significant risk factor for readmission due to dehydration following diverting ileostomy creation was revealed to be the ACEi and ARB use. In order to reduce this risk, consideration ought to be given to withholding these medications after ileostomy creation.